Disclosure Panels Details Page
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel - Disclosures as of 04/25/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Zahraa AlHilli MD | None | None | None | None | 01/03/2024 |
| Banu Arun MD | AstraZeneca Pharmaceuticals LP | None | None | None | 01/29/2024 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Saundra Buys MD | None | None | None | None | 02/05/2024 |
| Heather Cheng PhD,MD | Clovis Oncology Color Health, Inc Janssen Pharmaceutica Products, LP Promontory Therapeutics (formerly Phosplatin) |
None | None | UpToDate | 12/22/2023 |
| Jane Churpek MS,MD | Department of Defense NIH |
MDS Foundation RUNX1 Research Program |
None | MDS Foundation|RUNX1 Research Program | 04/24/2024 |
| Mary Daly PhD,MD,FACP | None | None | None | None | 01/25/2024 |
| Susan Darlow PhD | None | None | None | None | 04/17/2024 |
| Zeenat Diwan PhD,MS | None | None | None | None | 12/11/2023 |
| Susan Domchek MD | Glade Therapuetics | None | None | None | 03/18/2024 |
| Mary Dwyer MS | None | None | None | None | 02/12/2024 |
| Susan Friedman DVM | None | None | None | None | 02/05/2024 |
| Veda Giri MD | None | None | None | None | 03/25/2024 |
| Michael Goggins MD | None | None | None | None | 12/27/2023 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Andrea Hagemann MD,MSCI | None | None | None | None | 11/27/2023 |
| Ashley Hendrix MD,MBA | None | None | None | None | 04/02/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Dezheng Huo PhD | None | None | None | None | 04/24/2024 |
| Mollie Hutton MS,CGC | None | None | None | None | 01/03/2024 |
| Beth Karlan MD | GRAIL | ACS BrightEdge ClearNote Foundation Medicine Global Coalition for Adaptive Research Invitae Mercy BioAnalytics Ovarian Cancer Research Alliance |
None | None | 04/23/2024 |
| Nawal Kassem MS,MD | None | None | None | None | 03/18/2024 |
| Seema Khan MD | None | Besins Healthcare Ireland Ltd. | None | None | 12/22/2023 |
| Katia Khoury MD | None | None | None | None | 02/11/2024 |
| Allison Kurian MSc,MD | Ambry Genetics Color Health GeneDx Gilead Sciences, Inc. GRAIL Invitae Merck & Co., Inc. Myriad Genetic Laboratories, Inc. |
None | None | None | 04/11/2024 |
| Christine Laronga MD,FACS | None | None | None | Royalties for editorial work | 01/28/2024 |
| Julie Mak MSc,MS,CGC | None | None | None | VSee | 11/28/2023 |
| John Mansour MD | None | None | None | None | 02/05/2024 |
| Kara Maxwell PhD,MD | None | None | None | None | 03/19/2024 |
| Kevin McDonnell PhD,MD | None | None | None | None | 02/03/2024 |
| Carolyn Menendez MD | None | None | None | None | 04/16/2024 |
| Sofia Merajver PhD,MD | Inheret, LLC National Institutes of Health |
Inheret, LLC | None | Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. | 02/05/2024 |
| Barbara Norquist MD | None | None | None | None | 03/18/2024 |
| Kenneth Offit MD,MPH | None | None | None | None | 04/04/2024 |
| Tuya Pal MD | None | None | None | None | 02/27/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Dominique Rash MD | None | None | None | None | 02/06/2024 |
| Gwen Reiser MS,CGC | None | None | None | None | 03/18/2024 |
| Leigha Senter-Jamieson MS,CGC | None | AstraZeneca Pharmaceuticals LP | AstraZeneca Pharmaceuticals LP | None | 01/03/2024 |
| Kristen Shannon MS,CGC | None | None | None | None | 04/07/2024 |
| Kala Visvanathan MHS,MD | Cepheid Optra Health |
Evolveimmune Therapeutics Vera Medical Institute |
None | None | 03/18/2024 |
| Jeanna Welborn MD | None | None | None | None | 02/20/2024 |
| Myra Wick MD,PhD | Natera | American board of Medical Genetics and Genomics (ABMGG) | None | None | 03/05/2024 |
| Marie Wood MD | None | None | None | None | 03/18/2024 |
| Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | Nouscom UpToDate |
None | Facing Our Risk of Cancer Empowered (FORCE) advocacy group | 03/16/2024 |